Related references
Note: Only part of the references are listed.Viral vectors as vaccine platforms: from immunogenicity to impact
Katie J. Ewer et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8+ T-cell responses: The immunological consequences of the biodistribution profile
Signe Tandrup Schmidt et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies
Diego A. Espinosa et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
H. Tinto et al.
LANCET (2015)
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
Michael T. White et al.
LANCET INFECTIOUS DISEASES (2015)
Gaps in knowledge and prospects for research of adjuvanted vaccines
Robert Seder et al.
VACCINE (2015)
A Full-Length Plasmodium falciparum Recombinant Circumsporozoite Protein Expressed by Pseudomonas fluorescens Platform as a Malaria Vaccine Candidate
Amy R. Noe et al.
PLOS ONE (2014)
Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant
Karen Smith Korsholm et al.
VACCINE (2014)
Full-Length Plasmodium falciparum Circumsporozoite Protein Administered with Long-Chain Poly(I.C) or the Toll-Like Receptor 4 Agonist Glucopyranosyl Lipid Adjuvant-Stable Emulsion Elicits Potent Antibody and CD4+ T Cell Immunity and Protection in Mice
Kathrin Kastenmueller et al.
INFECTION AND IMMUNITY (2013)
Novel vaccine strategies against emerging viruses
Adolfo Garcia-Sastre et al.
CURRENT OPINION IN VIROLOGY (2013)
License to kill: Formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems
Camilla Foged et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
Sara Mian-McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The RTS,S vaccine candidate for malaria
Jason A. Regules et al.
EXPERT REVIEW OF VACCINES (2011)
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial
Ally Olotu et al.
LANCET INFECTIOUS DISEASES (2011)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Induction of Plasmodium falciparum-Specific CD4+ T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01E and RTS,S/AS02D
Selidji T. Agnandji et al.
PLOS ONE (2011)
Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01E and Protection against P falciparum Clinical Malaria
Ally Olotu et al.
PLOS ONE (2011)
Immune mechanisms of protection: can adjuvants rise to the challenge?
Amy S. McKee et al.
BMC BIOLOGY (2010)
Vaccine Adjuvants: Putting Innate Immunity to Work
Robert L. Coffman et al.
IMMUNITY (2010)
Further Analysis of Correlates of Protection from a Phase 2a Trial of the Falciparum Malaria Vaccines RTS, S/AS01B and RTS, S/AS02A in Malaria-Naive Adults
Ally Ibrahim Olotu et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kent E. Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Viral vectors in malaria vaccine development
K. J. Limbach et al.
PARASITE IMMUNOLOGY (2009)
Protective CD8(+) T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response
Michael Glen Overstreet et al.
IMMUNOLOGICAL REVIEWS (2008)
Memory CD8(+) T cell responses expand when antigen presentation overcomes T cell self-regulation
Ian A. Cockburn et al.
JOURNAL OF IMMUNOLOGY (2008)
Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A
Douglas S. Walsh et al.
VACCINE (2006)
A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS
SJ Dunachie et al.
VACCINE (2006)
High efficiency transfection of Plasmodium berghei facilitates novel selection procedures
CJ Janse et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2006)
Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes
DL Medica et al.
INFECTION AND IMMUNITY (2005)
Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A
JE Epstein et al.
VACCINE (2004)
Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia
M Pinder et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Efficacy of RTS,S/ASO2 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia:: a randomised trial
KA Bojang et al.
LANCET (2001)
Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR
O Bruña-Romero et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2001)
Share Paper
